Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

CompletedOBSERVATIONAL
Enrollment

943

Participants

Timeline

Start Date

July 18, 2014

Primary Completion Date

October 28, 2016

Study Completion Date

October 28, 2016

Conditions
Chemotherapy-induced Febrile Neutropenia
Trial Locations (74)

1030

Research Site, Vienna

1090

Research Site, Vienna

1756

Research Site, Sofia

3730

Research Site, Eggenburg

4000

Research Site, Liège

5620

Research Site, Schwarzach im Pongau

5800

Research Site, Pleven

6700

Research Site, Arlon

8036

Research Site, Graz

8700

Research Site, Leoben

11526

Research Site, Papagou

11527

Research Site, Athens

11528

Research Site, Athens

12462

Research Site, Athens

13009

Research Site, Marseille

13100

Research Site, Aix-en-Provence

13385

Research Site, Marseille

14564

Research Site, Nea Kifissia, Athens

18537

Research Site, Piraeus

24004

Research Site, Périgueux

24100

Research Site, Kalamata

26655

Research Site, Westerstede

30029

Research Site, Nîmes

31134

Research Site, Hildesheim

34119

Research Site, Kassel

36043

Research Site, Fulda

41110

Research Site, Larissa

42270

Research Site, Saint-Priest-en-Jarez

42551

Research Site, Velbert

45067

Research Site, Orléans

52222

Research Site, Stolberg

53111

Research Site, Bonn

53840

Research Site, Troisdorf

54100

Research Site, Nancy

54622

Research Site, Thessaloniki

54636

Research Site, Thessaloniki

54645

Research Site, Thessaloniki

55236

Research Site, Thessaloniki

62660

Research Site, Beuvry

66000

Research Site, Perpignan

67000

Research Site, Strasbourg

69495

Research Site, Pierre-Bénite

73300

Research Site, Chania

77100

Research Site, Meaux

80000

Research Site, Amiens

95200

Research Site, Sarcelles

100337

Research Site, Ploieşti

105600

Research Site, Câmpina

400124

Research Site, Cluj-Napoca

410469

Research Site, Oradea

430031

Research Site, Baia Mare

700483

Research Site, Iași

810325

Research Site, Brăila

430 12

Research Site, Chomutov

268 31

Research Site, Hořovice

741 01

Research Site, Nový Jičín

304 60

Research Site, Pilsen

100 34

Research Site, Prague

128 08

Research Site, Prague

01307

Research Site, Dresden

15-027

Research Site, Bialystok

81-519

Research Site, Gdynia

75-581

Research Site, Koszalin

31-501

Research Site, Krakow

31-531

Research Site, Krakow

61-485

Research Site, Poznan

02-097

Research Site, Warsaw

02-781

Research Site, Warsaw

58-309

Research Site, Wałbrzych

010825

Research Site, Bucharest

022328

Research Site, Bucharest

022338

Research Site, Bucharest

030171

Research Site, Bucharest

031864

Research Site, Bucharest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY